Welcome to ASMI2021

The ASMI 2021 conference committee would like to wholeheartedly welcome you to the 6th Annual Scientific Symposium hosted by the Australian Society of Molecular Imaging (ASMI). We’re bringing together researchers from a wide range of disciplines interested in the development and application of multi-modality molecular imaging.
Check out the Program for more details.

We expect to host around 150 researchers from fundamental and applied areas of chemistry, biology, imaging, and clinical research. Early career researchers and higher degree students are welcomed – the Registration page will soon be updated with information.

ASMI 2021 will be held in the Translational Research Institute (TRI) in Woollongabba, Queensland from Monday 21 to Tuesday 22 June 2021 with a special CAI Workshop on 23 June 2021. The Logistics page contains venue, accommodation, tourism, and more useful information for planning your visit to Brisbane.

Plenary Speakers

Image of Carolyn, smiling
Prof Carolyn MountfordQueensland University of Technology

Professor Carolyn Mountford is an Oxford Educated Biophysicist. She recently stepped down as CEO and Director of Research for Australia’s Translational Research Institute. Carolyn was awarded full Professor of Radiology at Harvard Medical School in 2011 and retains a position as NeuroScientist at the Athinoula A. Martinos Center for Biomedical Imaging at MGH and Harvard Medical School. She is currently Professor of Radiology at QUT and CEO of a start up DatChem. Professor Mountford and her team have been a worldwide development site for Siemens since 1999. She is a co-inventor of the diagnostic protocol to monitor women at high risk for breast cancer identifying metabolic deregulations in their breast tissue that precede tumour growth. The same technology is shown to identify changes to the brain associated with learning, memory, Post-Traumatic Stress Disorder (PTSD) and injury from blast and impact. Her team is under contract to the USA and Australian military to develop this approach to improve the health of soldiers.

Image of Carolyn, smiling
Prof Carolyn MountfordQueensland University of Technology

Professor Carolyn Mountford is an Oxford Educated Biophysicist. She recently stepped down as CEO and Director of Research for Australia’s Translational Research Institute. Carolyn was awarded full Professor of Radiology at Harvard Medical School in 2011 and retains a position as NeuroScientist at the Athinoula A. Martinos Center for Biomedical Imaging at MGH and Harvard Medical School. She is currently Professor of Radiology at QUT and CEO of a start up DatChem. Professor Mountford and her team have been a worldwide development site for Siemens since 1999. She is a co-inventor of the diagnostic protocol to monitor women at high risk for breast cancer identifying metabolic deregulations in their breast tissue that precede tumour growth. The same technology is shown to identify changes to the brain associated with learning, memory, Post-Traumatic Stress Disorder (PTSD) and injury from blast and impact. Her team is under contract to the USA and Australian military to develop this approach to improve the health of soldiers.

closepopup
Kris profile photo, smiling
Prof Kristofer ThurechtUniversity of Queensland

Prof. Kristofer Thurecht graduated from the University of Queensland, Australia, in 2005 with a PhD in polymer chemistry. In 2007, Prof. Thurecht was simultaneously awarded a Ramsay Centenary Fellowship and 1851 Research Fellowship in the UK, and has since held both an ARC Australian Postdoctoral Fellowship (2008) and an ARC Future Fellowship (2012). In 2015, Prof. Thurecht was awarded the RACI David Sangster Polymer Science and Technology Award from the Polymer Division. Prof. Thurecht is a senior group leader within the Centre for Advanced Imaging (CAI) and the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland where he currently holds an NHMRC Career Development Fellowship (CDF2). His research focusses on developing improved understanding of the nano-bio interface, particularly using molecular imaging tools to address some of the complex questions in this field. His team works across the boundaries of chemistry and materials, biology and imaging science to probe how nanomaterial properties affect their function in living animals. He is a CI in the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and theme leader in the ARC Training Centre for Innovation in Biomedical Imaging and Technology.

Kris profile photo, smiling
Prof Kristofer ThurechtUniversity of Queensland

Prof. Kristofer Thurecht graduated from the University of Queensland, Australia, in 2005 with a PhD in polymer chemistry. In 2007, Prof. Thurecht was simultaneously awarded a Ramsay Centenary Fellowship and 1851 Research Fellowship in the UK, and has since held both an ARC Australian Postdoctoral Fellowship (2008) and an ARC Future Fellowship (2012). In 2015, Prof. Thurecht was awarded the RACI David Sangster Polymer Science and Technology Award from the Polymer Division. Prof. Thurecht is a senior group leader within the Centre for Advanced Imaging (CAI) and the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland where he currently holds an NHMRC Career Development Fellowship (CDF2). His research focusses on developing improved understanding of the nano-bio interface, particularly using molecular imaging tools to address some of the complex questions in this field. His team works across the boundaries of chemistry and materials, biology and imaging science to probe how nanomaterial properties affect their function in living animals. He is a CI in the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and theme leader in the ARC Training Centre for Innovation in Biomedical Imaging and Technology.

closepopup

Invited Speakers

Prof Gemma FigtreeUniversity of Sydney

Gemma Figtree is a Professor in Medicine at the University of Sydney. She co-leads the Cardiovascular Theme for Sydney Health Partners, a NHMRC Advanced Health Research and Translation Centre and is the Chair of the University of Sydney’s multi-disciplinary Cardiovascular Initiative. Gemma completed her DPhil at Oxford University in 2002 supported by a Rhodes Scholarship making fundamental discoveries regarding estrogen’s actions and factors regulating NO/redox balance in the cardiovascular system. She is committed to improving the care for heart attack patients- using her knowledge of molecular and cellular biology to develop methods of identifying those at highest risk of adverse outcome, and discovering novel therapies to prevent and treat events, inspired by her clinical work as an interventional cardiologist. She has dedicated herself throughout her career to unravelling key mechanisms underlying susceptibility and response to heart attack, with studies extending from the bench to large cohort studies and clinical trials. Discoveries in her Laboratory have been published in leading journals Circulation, JACC and European Heart Journal, with > 140 publications. GF is a principal investigator on grants >$8 mill. Having recently completed a co-funded NHMRC CDF and Heart Foundation Future Leader Fellowship, she was awarded a National Health and Medical Research Council (NHMRC) Excellence Award for Top Ranked Practitioner Fellow (Australia), commencing in 2018. In 2019 she received the prestigious NSW Ministerial Award for Cardiovascular Research Excellence. Gemma is committed to the advancement of her field and serves as a member of the Editorial Board of leading international cardiovascular journals Circulation and Cardiovascular Research, as well as being a founding editorial board member for Redox Biology, and an Associate Editor for Heart, Lung and Circulation. Her research and clinical perspective and leadership are recognised by her membership of the Scientific Board of Cardiac Society of Australia and New Zealand (responsible for International Relations), and her appointment to the Expert Advisory Panel for NHMRC Structural Review of Grants Program (2016-17), and as well as the Clinical Committee of the Heart Foundation. She is committed to the promotion and advocacy of cardiovascular research, working as President of the Australian Cardiovascular Alliance with a national team to secure $220 Million Federal funding for the Mission for Cardiovascular Health, as well as a member of the NSW CVD Advisory Committee. She now chairs the Mission (CV) Expert Advisory Panel. She is a graduate of the Australian Institute of Company Directors and serves/has served as a non-executive Director on multiple community Boards.

Prof Gemma FigtreeUniversity of Sydney

Gemma Figtree is a Professor in Medicine at the University of Sydney. She co-leads the Cardiovascular Theme for Sydney Health Partners, a NHMRC Advanced Health Research and Translation Centre and is the Chair of the University of Sydney’s multi-disciplinary Cardiovascular Initiative. Gemma completed her DPhil at Oxford University in 2002 supported by a Rhodes Scholarship making fundamental discoveries regarding estrogen’s actions and factors regulating NO/redox balance in the cardiovascular system. She is committed to improving the care for heart attack patients- using her knowledge of molecular and cellular biology to develop methods of identifying those at highest risk of adverse outcome, and discovering novel therapies to prevent and treat events, inspired by her clinical work as an interventional cardiologist. She has dedicated herself throughout her career to unravelling key mechanisms underlying susceptibility and response to heart attack, with studies extending from the bench to large cohort studies and clinical trials. Discoveries in her Laboratory have been published in leading journals Circulation, JACC and European Heart Journal, with > 140 publications. GF is a principal investigator on grants >$8 mill. Having recently completed a co-funded NHMRC CDF and Heart Foundation Future Leader Fellowship, she was awarded a National Health and Medical Research Council (NHMRC) Excellence Award for Top Ranked Practitioner Fellow (Australia), commencing in 2018. In 2019 she received the prestigious NSW Ministerial Award for Cardiovascular Research Excellence. Gemma is committed to the advancement of her field and serves as a member of the Editorial Board of leading international cardiovascular journals Circulation and Cardiovascular Research, as well as being a founding editorial board member for Redox Biology, and an Associate Editor for Heart, Lung and Circulation. Her research and clinical perspective and leadership are recognised by her membership of the Scientific Board of Cardiac Society of Australia and New Zealand (responsible for International Relations), and her appointment to the Expert Advisory Panel for NHMRC Structural Review of Grants Program (2016-17), and as well as the Clinical Committee of the Heart Foundation. She is committed to the promotion and advocacy of cardiovascular research, working as President of the Australian Cardiovascular Alliance with a national team to secure $220 Million Federal funding for the Mission for Cardiovascular Health, as well as a member of the NSW CVD Advisory Committee. She now chairs the Mission (CV) Expert Advisory Panel. She is a graduate of the Australian Institute of Company Directors and serves/has served as a non-executive Director on multiple community Boards.

closepopup
John Hooper smiling at the camera
Prof John HooperMater Research Institute
John Hooper smiling at the camera
Prof John HooperMater Research Institute
closepopup
trent in a lab smiling at the camera
Prof Trent WoodruffUniversity of Queensland
trent in a lab smiling at the camera
Prof Trent WoodruffUniversity of Queensland
closepopup
Prof Tanya SmithGriffith University

Dr. Tanya Smith is a Professor in the Australian Research Centre for Human Evolution and the Griffith Centre for Social and Cultural Research at Griffith University. She has previously held a professorship at Harvard University and fellowships at the Radcliffe Institute for Advanced Study and the Max Planck Institute for Evolutionary Anthropology. Professor Smith explores the evolution and development of the human dentition. Teeth preserve remarkably faithful records of daily growth and infant diet - as well as stress experienced during birth - for millions of years. Her research has helped to identify of the origins of a fundamental human adaptation: the costly yet advantageous shift from a “live fast and die young” strategy to the “live slow and grow old” strategy that has helped to make us one of the most successful mammals on the planet. Professor Smith’s research has been funded by the Australian Academy of Sciences and the US National Science Foundation, and published in Nature, Proceedings of the National Academy of Sciences, and Science Advances. It has been highlighted in the New York Times, National Geographic, Nature, Science, Smithsonian, and Discovery magazines, as well as through American, Australian, British, Canadian, French, German, Irish, New Zealand, and Singaporean broadcast media.

Prof Tanya SmithGriffith University

Dr. Tanya Smith is a Professor in the Australian Research Centre for Human Evolution and the Griffith Centre for Social and Cultural Research at Griffith University. She has previously held a professorship at Harvard University and fellowships at the Radcliffe Institute for Advanced Study and the Max Planck Institute for Evolutionary Anthropology. Professor Smith explores the evolution and development of the human dentition. Teeth preserve remarkably faithful records of daily growth and infant diet - as well as stress experienced during birth - for millions of years. Her research has helped to identify of the origins of a fundamental human adaptation: the costly yet advantageous shift from a “live fast and die young” strategy to the “live slow and grow old” strategy that has helped to make us one of the most successful mammals on the planet. Professor Smith’s research has been funded by the Australian Academy of Sciences and the US National Science Foundation, and published in Nature, Proceedings of the National Academy of Sciences, and Science Advances. It has been highlighted in the New York Times, National Geographic, Nature, Science, Smithsonian, and Discovery magazines, as well as through American, Australian, British, Canadian, French, German, Irish, New Zealand, and Singaporean broadcast media.

closepopup
A/Prof Juliana HamzahHarry Perkins Institute of Medical Research
A/Prof Juliana HamzahHarry Perkins Institute of Medical Research
closepopup
Dr Xiaowei WangBaker Heart and Diabetes Institute
Dr Xiaowei WangBaker Heart and Diabetes Institute
closepopup
Dr Xiaowen LiangUniversity of Queensland Diamantina Institute

Dr Xiaowen Liang awarded her PhD from The University of Queensland (UQ) in 2015 and received the Dean’s Award for outstanding Research Higher Degree Theses (top 10% of UQ graduates). She is a UQ Development Fellow and the focus of her work is on the use of advanced technologies to improve liver cancer outcomes and in managing drug induced liver injury. She has published a total of 4 book chapters and 46 peer-reviewed articles (7 as first author and 14 as corresponding author) in high-quality journals such as Advanced Science, Theranostics, ACS Nano and Hepatology. She has attracted over $770,000 as CIA including NHMRC New Investigator Project Grant, UQ Development Fellowship, and Global Connection Fund Priming Grant. Currently, she supervises one PhD student and one Honours student as principal supervisor and co-supervises 3 PhD students.

Dr Xiaowen LiangUniversity of Queensland Diamantina Institute

Dr Xiaowen Liang awarded her PhD from The University of Queensland (UQ) in 2015 and received the Dean’s Award for outstanding Research Higher Degree Theses (top 10% of UQ graduates). She is a UQ Development Fellow and the focus of her work is on the use of advanced technologies to improve liver cancer outcomes and in managing drug induced liver injury. She has published a total of 4 book chapters and 46 peer-reviewed articles (7 as first author and 14 as corresponding author) in high-quality journals such as Advanced Science, Theranostics, ACS Nano and Hepatology. She has attracted over $770,000 as CIA including NHMRC New Investigator Project Grant, UQ Development Fellowship, and Global Connection Fund Priming Grant. Currently, she supervises one PhD student and one Honours student as principal supervisor and co-supervises 3 PhD students.

closepopup